Quanterix Co. (NASDAQ:QTRX) Shares Bought by Strs Ohio

Strs Ohio raised its position in Quanterix Co. (NASDAQ:QTRX) by 5.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 18,400 shares of the company’s stock after purchasing an additional 1,000 shares during the period. Strs Ohio’s holdings in Quanterix were worth $503,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Quanterix by 1.4% in the third quarter. Vanguard Group Inc. now owns 1,997,295 shares of the company’s stock valued at $54,207,000 after purchasing an additional 26,660 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Quanterix by 49.6% during the third quarter. Invesco Ltd. now owns 1,103,981 shares of the company’s stock valued at $29,962,000 after acquiring an additional 366,117 shares during the last quarter. Lord Abbett & CO. LLC acquired a new stake in shares of Quanterix during the third quarter valued at $27,744,000. Boone Capital Management LLC boosted its stake in shares of Quanterix by 13.4% during the third quarter. Boone Capital Management LLC now owns 568,544 shares of the company’s stock valued at $15,430,000 after acquiring an additional 67,400 shares during the last quarter. Finally, Emerald Advisers LLC acquired a new stake in shares of Quanterix during the third quarter valued at $10,462,000. Institutional investors and hedge funds own 86.48% of the company’s stock.

Analyst Ratings Changes

Separately, Scotiabank increased their price objective on Quanterix from $30.00 to $32.00 and gave the company a “sector outperform” rating in a research note on Monday, March 4th. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Quanterix has a consensus rating of “Buy” and a consensus target price of $32.00.

Quanterix Trading Down 0.2 %

Shares of NASDAQ:QTRX opened at $15.56 on Friday. The stock’s 50-day moving average price is $22.74 and its two-hundred day moving average price is $23.33. Quanterix Co. has a 12-month low of $11.60 and a 12-month high of $29.70. The firm has a market cap of $595.17 million, a price-to-earnings ratio of -18.09 and a beta of 1.30.

Quanterix (NASDAQ:QTRX) last issued its quarterly earnings results on Thursday, February 29th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.05). Quanterix had a negative return on equity of 9.15% and a negative net margin of 26.42%. The business had revenue of $31.55 million during the quarter, compared to analyst estimates of $27.92 million. As a group, research analysts forecast that Quanterix Co. will post -1.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Quanterix news, Director Laurie J. Olson sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, February 14th. The stock was sold at an average price of $24.35, for a total value of $36,525.00. Following the sale, the director now directly owns 15,238 shares of the company’s stock, valued at approximately $371,045.30. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 6.80% of the stock is owned by corporate insiders.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.